Skip to main content

Table 5 Association between TG/HDL-C ratio(per 1 unit increase) and AF recurrence

From: Non-insulin-based insulin resistance indexes in predicting atrial fibrillation recurrence following ablation: a retrospective study

 

Model 10

Model 11

Model 12

HR (95%CI)

P value

HR (95% CI)

P value

HR (95% CI)

P value

TG/HDL-C ratio

1.03 (1.00-1.06)

0.050

1.03 (1.01–1.06)

0.021

1.03 (1.00-1.06)

0.055

< 3.272

Reference

Reference

Reference

≥ 3.272

1.22 (1.05–1.42)

0.010

1.26 (1.08–1.47)

0.003

1.22 (1.04–1.43)

0.017

G1

Reference

Reference

Reference

G2

0.98 (0.81–1.18)

0.822

0.99 (0.82–1.19)

0.921

0.91 (0.75–1.10)

0.343

G3

1.19 (0.99–1.42)

0.059

1.23 (1.03–1.48)

0.022

1.13 (0.94–1.37)

0.195

  1. AF, atrial fibrillation; CI, confidence interval; HR, hazard ratio; TG/HDL-C, triglyceride to high-density lipoprotein cholesterol; G1: TG/HDL-C ratio ≤ 2.097; G2: 2.097 < TG/HDL-C ratio ≤ 3.287; G3: 3.287 < TG/HDL-C ratio
  2. Model 10: Unadjusted
  3. Model 11: Adjusted for age and sex
  4. Model 12: Adjusted for age, sex, body mass index, current drinking, diabetes mellitus, hyperlipidemia, coronary heart disease, duration of AF (≥ 24 months), AF type, fasting blood glucose, HbA1c, left atrial diameter, platelet, CHA2DS2-VASc score